• Home
  • US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy.

US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy.

Author List
Velarde N, Westphalen AC, Nguyen HG, Neuhaus J, Shinohara K, Simko JP, Larson PE, Magudia K
Publication
Abdominal radiology (New York)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/254274976
Publication Year
2022
PubMed ID
34997299
Publication Title
Velarde N, Westphalen AC, Nguyen HG, Neuhaus J, Shinohara K, Simko JP, Larson PE, Magudia K. US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy. Abdom Radiol (NY). 2022 03; 47(3):1133-1141.